Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors

Overview of attention for article published in Cancer Immunology Research, June 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 1 news story.

Follow Summary A third patient dosed last quarter should have 12-week data next month.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.